RxDoctor Payments Data

David Fahey, DO

Family Medicine · Independence, IANPI 1467833632

Payments from drug & device makers

$1,647in general payments, 2019–2025

Across 119 payments — averaging $13.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$351
  • AstraZeneca$224
  • Organogenesis Inc.$198
  • Johnson & Johnson$128
  • Pfizer$115
  • Amgen$113
  • plus $518 from 18 others

What the payments were for

  • Food & beverage$1,62799%
  • Education$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,647 in reported general payments places this provider in the 85th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$10,912
Medicare patients
51
Services billed
136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban130$88,996
JardianceEmpagliflozin94$59,493
OzempicSemaglutide48$58,103
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$35,880
XareltoRivaroxaban51$30,149
TrulicityDulaglutide24$24,752
Breo ElliptaFluticasone/Vilanterol31$12,361
Victoza 3-PakLiraglutide12$9,518
Paliperidone ErPaliperidone23$7,595
Lantus SolostarInsulin Glargine,hum.Rec.Anlog59$6,112
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$6,015
MyrbetriqMirabegron25$5,738
Spiriva RespimatTiotropium Bromide11$5,647
Potassium Chloride167$5,341
Gabapentin206$5,176

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$115$88,996130 claims
Boehringer IngelheimJardiance, Spiriva Respimat$48$65,140105 claims
Novo NordiskOzempic$90$58,10348 claims
Johnson & JohnsonXarelto$128$30,14951 claims
Lilly USA, LLCTrulicity$28$24,75224 claims
Astellas Pharma US IncMyrbetriq$17$5,73825 claims
Sanofi-aventis U.S. LLCLantus$15$2,52919 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Independence

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →